Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): IBC-Ab002

            Therapeutic Area: Neurology Product Name: IBC-Ab002

            Highest Development Status: Phase I Product Type: Large molecule

            Partner/Sponsor/Collaborator: Alzheimer’s Association

            Deal Size: $1.0 million Upfront Cash: Undisclosed

            Deal Type: Funding September 01, 2020


            The grant will phase 1 clinical trial to examine safety and activity of its proprietary antibody, IBC-Ab002, targeted to enhance the immune system and induce brain repair processes in individuals with Alzheimer’s disease.